Clinical Trial Update: Natural History Study in Pediatric Patients with STXBP1 Encephalopathy with Epilepsy

View source ↗

Summary

A natural history study in pediatric patients with STXBP1 encephalopathy with epilepsy has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stxbp1 Encephalopathy with Epilepsy

Snippet

Sponsor: Capsida Biotherapeutics, Inc. | Conditions: STXBP1 Encephalopathy with Epilepsy | Status: WITHDRAWN